Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant's health: cross-sectional linkage study.
Identifieur interne : 000067 ( Main/Exploration ); précédent : 000066; suivant : 000068Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant's health: cross-sectional linkage study.
Auteurs : N. Van Der Maas [Pays-Bas] ; J. Dijs-Elsinga [Pays-Bas] ; J. Kemmeren [Pays-Bas] ; A. Van Lier [Pays-Bas] ; M. Knol [Pays-Bas] ; H. De Melker [Pays-Bas]Source :
- BJOG : an international journal of obstetrics and gynaecology [ 1471-0528 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Analyse multifactorielle (MeSH), Complications infectieuses de la grossesse (prévention et contrôle), Enquêtes de santé (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grossesse (MeSH), Humains (MeSH), Issue de la grossesse (MeSH), Modèles linéaires (MeSH), Modèles logistiques (MeSH), Mémorisation et recherche des informations (MeSH), Nourrisson (MeSH), Nouveau-né (MeSH), Pays-Bas (MeSH), Résultat thérapeutique (MeSH), Santé infantile (MeSH), Sous-type H1N1 du virus de la grippe A (MeSH), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (effets indésirables), Études transversales (MeSH).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- effets indésirables : Vaccins antigrippaux.
- prévention et contrôle : Complications infectieuses de la grossesse, Grippe humaine.
- Adulte, Analyse multifactorielle, Enquêtes de santé, Femelle, Grossesse, Humains, Issue de la grossesse, Modèles linéaires, Modèles logistiques, Mémorisation et recherche des informations, Nourrisson, Nouveau-né, Pays-Bas, Résultat thérapeutique, Santé infantile, Sous-type H1N1 du virus de la grippe A, Études transversales.
English descriptors
- KwdEn :
- Adult (MeSH), Cross-Sectional Studies (MeSH), Female (MeSH), Health Surveys (MeSH), Humans (MeSH), Infant (MeSH), Infant Health (MeSH), Infant, Newborn (MeSH), Influenza A Virus, H1N1 Subtype (MeSH), Influenza Vaccines (administration & dosage), Influenza Vaccines (adverse effects), Influenza, Human (prevention & control), Information Storage and Retrieval (MeSH), Linear Models (MeSH), Logistic Models (MeSH), Multivariate Analysis (MeSH), Netherlands (MeSH), Pregnancy (MeSH), Pregnancy Complications, Infectious (prevention & control), Pregnancy Outcome (MeSH), Treatment Outcome (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , adverse effects : Influenza Vaccines.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- Adult, Cross-Sectional Studies, Female, Health Surveys, Humans, Infant, Infant Health, Infant, Newborn, Influenza A Virus, H1N1 Subtype, Information Storage and Retrieval, Linear Models, Logistic Models, Multivariate Analysis, Netherlands, Pregnancy, Pregnancy Outcome, Treatment Outcome.
Abstract
OBJECTIVE
This study aims to assess the safety of Influenza A(H1N1), vaccination administered during the second and third trimester and containing MF59 and thiomersal (Focetria(®) ), measured by pregnancy outcomes and infant's health.
DESIGN
Cross-sectional linkage study.
SETTING AND SAMPLE
A sample of pregnant women, eligible for prenatal screening, were invited to participate.
METHODS
Questionnaire data were linked with the Netherlands Perinatal Registry (n = 1920). Information on infant growth, development (n = 1739) and infection-related contacts with the general practitioner (GP) during the first year of life (n = 1671) was obtained.
MAIN OUTCOME MEASURES
Multivariate logistic regression was used to assess the association between H1N1 vaccination and small-for-gestational-age infant, preterm delivery and a composite adverse outcome, i.e. low Apgar-score, neonatal intensive care unit admission, neonatal resuscitation or perinatal death. Influence of maternal vaccination on growth, development and GP infection-related contact rates were assessed using multivariate linear mixed modelling and multivariate negative binomial regression, respectively.
RESULTS
Response rate was 21%. Though we found differences in characteristics between unvaccinated and vaccinated women, in the multivariate analyses no association was found between H1N1 vaccination and small-for-gestational-age (odds ratio [OR] 0.84; 95% confidence interval [95% CI] 0.50-1.43), preterm delivery (OR 0.98; 95% CI 0.59-1.62) and the composite adverse outcome (OR 0.84; 95% CI 0.44-1.60). We found no differences in weight-for-age (-0.05; 95% CI -0.13 to 0.04), length-for-age (-0.01; 95% CI -0.09 to 0.06), head-circumference-for-age (-0.05; 95% CI -0.13 to 0.03), developmental scores (-0.06; 95% CI -0.28 to 0.17) and infection-related GP contact rates (incidence rate ratio 1.07; 95% CI 0.91-1.28) between infants of unvaccinated and vaccinated mothers.
CONCLUSION
Pregnancy outcomes did not differ between H1N1-vaccinated and unvaccinated women. Furthermore, growth, development and GP infection-related contact rates, assessed after the first year of life, were similar in offspring of vaccinated and unvaccinated mothers.
TWEETABLE ABSTRACT
No increased risk for adverse pregnancy outcomes and infant's health following influenza vaccination.
DOI: 10.1111/1471-0528.13329
PubMed: 25754741
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant's health: cross-sectional linkage study.</title><author><name sortKey="Van Der Maas, N" sort="Van Der Maas, N" uniqKey="Van Der Maas N" first="N" last="Van Der Maas">N. Van Der Maas</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author><author><name sortKey="Dijs Elsinga, J" sort="Dijs Elsinga, J" uniqKey="Dijs Elsinga J" first="J" last="Dijs-Elsinga">J. Dijs-Elsinga</name><affiliation wicri:level="3"><nlm:affiliation>The Netherlands Perinatal Registry, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>The Netherlands Perinatal Registry, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Kemmeren, J" sort="Kemmeren, J" uniqKey="Kemmeren J" first="J" last="Kemmeren">J. Kemmeren</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author><author><name sortKey="Van Lier, A" sort="Van Lier, A" uniqKey="Van Lier A" first="A" last="Van Lier">A. Van Lier</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author><author><name sortKey="Knol, M" sort="Knol, M" uniqKey="Knol M" first="M" last="Knol">M. Knol</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author><author><name sortKey="De Melker, H" sort="De Melker, H" uniqKey="De Melker H" first="H" last="De Melker">H. De Melker</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:25754741</idno><idno type="pmid">25754741</idno><idno type="doi">10.1111/1471-0528.13329</idno><idno type="wicri:Area/Main/Corpus">000095</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000095</idno><idno type="wicri:Area/Main/Curation">000095</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000095</idno><idno type="wicri:Area/Main/Exploration">000095</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant's health: cross-sectional linkage study.</title><author><name sortKey="Van Der Maas, N" sort="Van Der Maas, N" uniqKey="Van Der Maas N" first="N" last="Van Der Maas">N. Van Der Maas</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author><author><name sortKey="Dijs Elsinga, J" sort="Dijs Elsinga, J" uniqKey="Dijs Elsinga J" first="J" last="Dijs-Elsinga">J. Dijs-Elsinga</name><affiliation wicri:level="3"><nlm:affiliation>The Netherlands Perinatal Registry, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>The Netherlands Perinatal Registry, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Kemmeren, J" sort="Kemmeren, J" uniqKey="Kemmeren J" first="J" last="Kemmeren">J. Kemmeren</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author><author><name sortKey="Van Lier, A" sort="Van Lier, A" uniqKey="Van Lier A" first="A" last="Van Lier">A. Van Lier</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author><author><name sortKey="Knol, M" sort="Knol, M" uniqKey="Knol M" first="M" last="Knol">M. Knol</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author><author><name sortKey="De Melker, H" sort="De Melker, H" uniqKey="De Melker H" first="H" last="De Melker">H. De Melker</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea><wicri:noRegion>Bilthoven</wicri:noRegion></affiliation></author></analytic><series><title level="j">BJOG : an international journal of obstetrics and gynaecology</title><idno type="eISSN">1471-0528</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Cross-Sectional Studies (MeSH)</term><term>Female (MeSH)</term><term>Health Surveys (MeSH)</term><term>Humans (MeSH)</term><term>Infant (MeSH)</term><term>Infant Health (MeSH)</term><term>Infant, Newborn (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (adverse effects)</term><term>Influenza, Human (prevention & control)</term><term>Information Storage and Retrieval (MeSH)</term><term>Linear Models (MeSH)</term><term>Logistic Models (MeSH)</term><term>Multivariate Analysis (MeSH)</term><term>Netherlands (MeSH)</term><term>Pregnancy (MeSH)</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnancy Outcome (MeSH)</term><term>Treatment Outcome (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Analyse multifactorielle (MeSH)</term><term>Complications infectieuses de la grossesse (prévention et contrôle)</term><term>Enquêtes de santé (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grossesse (MeSH)</term><term>Humains (MeSH)</term><term>Issue de la grossesse (MeSH)</term><term>Modèles linéaires (MeSH)</term><term>Modèles logistiques (MeSH)</term><term>Mémorisation et recherche des informations (MeSH)</term><term>Nourrisson (MeSH)</term><term>Nouveau-né (MeSH)</term><term>Pays-Bas (MeSH)</term><term>Résultat thérapeutique (MeSH)</term><term>Santé infantile (MeSH)</term><term>Sous-type H1N1 du virus de la grippe A (MeSH)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (effets indésirables)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Complications infectieuses de la grossesse</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Surveys</term><term>Humans</term><term>Infant</term><term>Infant Health</term><term>Infant, Newborn</term><term>Influenza A Virus, H1N1 Subtype</term><term>Information Storage and Retrieval</term><term>Linear Models</term><term>Logistic Models</term><term>Multivariate Analysis</term><term>Netherlands</term><term>Pregnancy</term><term>Pregnancy Outcome</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Analyse multifactorielle</term><term>Enquêtes de santé</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Issue de la grossesse</term><term>Modèles linéaires</term><term>Modèles logistiques</term><term>Mémorisation et recherche des informations</term><term>Nourrisson</term><term>Nouveau-né</term><term>Pays-Bas</term><term>Résultat thérapeutique</term><term>Santé infantile</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>This study aims to assess the safety of Influenza A(H1N1), vaccination administered during the second and third trimester and containing MF59 and thiomersal (Focetria(®) ), measured by pregnancy outcomes and infant's health.</p></div><div type="abstract" xml:lang="en"><p><b>DESIGN</b></p><p>Cross-sectional linkage study.</p></div><div type="abstract" xml:lang="en"><p><b>SETTING AND SAMPLE</b></p><p>A sample of pregnant women, eligible for prenatal screening, were invited to participate.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Questionnaire data were linked with the Netherlands Perinatal Registry (n = 1920). Information on infant growth, development (n = 1739) and infection-related contacts with the general practitioner (GP) during the first year of life (n = 1671) was obtained.</p></div><div type="abstract" xml:lang="en"><p><b>MAIN OUTCOME MEASURES</b></p><p>Multivariate logistic regression was used to assess the association between H1N1 vaccination and small-for-gestational-age infant, preterm delivery and a composite adverse outcome, i.e. low Apgar-score, neonatal intensive care unit admission, neonatal resuscitation or perinatal death. Influence of maternal vaccination on growth, development and GP infection-related contact rates were assessed using multivariate linear mixed modelling and multivariate negative binomial regression, respectively.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Response rate was 21%. Though we found differences in characteristics between unvaccinated and vaccinated women, in the multivariate analyses no association was found between H1N1 vaccination and small-for-gestational-age (odds ratio [OR] 0.84; 95% confidence interval [95% CI] 0.50-1.43), preterm delivery (OR 0.98; 95% CI 0.59-1.62) and the composite adverse outcome (OR 0.84; 95% CI 0.44-1.60). We found no differences in weight-for-age (-0.05; 95% CI -0.13 to 0.04), length-for-age (-0.01; 95% CI -0.09 to 0.06), head-circumference-for-age (-0.05; 95% CI -0.13 to 0.03), developmental scores (-0.06; 95% CI -0.28 to 0.17) and infection-related GP contact rates (incidence rate ratio 1.07; 95% CI 0.91-1.28) between infants of unvaccinated and vaccinated mothers.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Pregnancy outcomes did not differ between H1N1-vaccinated and unvaccinated women. Furthermore, growth, development and GP infection-related contact rates, assessed after the first year of life, were similar in offspring of vaccinated and unvaccinated mothers.</p></div><div type="abstract" xml:lang="en"><p><b>TWEETABLE ABSTRACT</b></p><p>No increased risk for adverse pregnancy outcomes and infant's health following influenza vaccination.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25754741</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0528</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>BJOG : an international journal of obstetrics and gynaecology</Title><ISOAbbreviation>BJOG</ISOAbbreviation></Journal><ArticleTitle>Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant's health: cross-sectional linkage study.</ArticleTitle><Pagination><MedlinePgn>709-17</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1471-0528.13329</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to assess the safety of Influenza A(H1N1), vaccination administered during the second and third trimester and containing MF59 and thiomersal (Focetria(®) ), measured by pregnancy outcomes and infant's health.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Cross-sectional linkage study.</AbstractText><AbstractText Label="SETTING AND SAMPLE" NlmCategory="METHODS">A sample of pregnant women, eligible for prenatal screening, were invited to participate.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Questionnaire data were linked with the Netherlands Perinatal Registry (n = 1920). Information on infant growth, development (n = 1739) and infection-related contacts with the general practitioner (GP) during the first year of life (n = 1671) was obtained.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Multivariate logistic regression was used to assess the association between H1N1 vaccination and small-for-gestational-age infant, preterm delivery and a composite adverse outcome, i.e. low Apgar-score, neonatal intensive care unit admission, neonatal resuscitation or perinatal death. Influence of maternal vaccination on growth, development and GP infection-related contact rates were assessed using multivariate linear mixed modelling and multivariate negative binomial regression, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Response rate was 21%. Though we found differences in characteristics between unvaccinated and vaccinated women, in the multivariate analyses no association was found between H1N1 vaccination and small-for-gestational-age (odds ratio [OR] 0.84; 95% confidence interval [95% CI] 0.50-1.43), preterm delivery (OR 0.98; 95% CI 0.59-1.62) and the composite adverse outcome (OR 0.84; 95% CI 0.44-1.60). We found no differences in weight-for-age (-0.05; 95% CI -0.13 to 0.04), length-for-age (-0.01; 95% CI -0.09 to 0.06), head-circumference-for-age (-0.05; 95% CI -0.13 to 0.03), developmental scores (-0.06; 95% CI -0.28 to 0.17) and infection-related GP contact rates (incidence rate ratio 1.07; 95% CI 0.91-1.28) between infants of unvaccinated and vaccinated mothers.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pregnancy outcomes did not differ between H1N1-vaccinated and unvaccinated women. Furthermore, growth, development and GP infection-related contact rates, assessed after the first year of life, were similar in offspring of vaccinated and unvaccinated mothers.</AbstractText><AbstractText Label="TWEETABLE ABSTRACT" NlmCategory="CONCLUSIONS">No increased risk for adverse pregnancy outcomes and infant's health following influenza vaccination.</AbstractText><CopyrightInformation>© 2015 Royal College of Obstetricians and Gynaecologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Maas</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dijs-Elsinga</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Netherlands Perinatal Registry, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kemmeren</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Lier</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knol</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Melker</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJOG</MedlineTA><NlmUniqueID>100935741</NlmUniqueID><ISSNLinking>1470-0328</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C558220">focetria</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068104" MajorTopicYN="Y">Infant Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="Y">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Infant</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">safety</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25754741</ArticleId><ArticleId IdType="doi">10.1111/1471-0528.13329</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country><region><li>Utrecht (province)</li></region><settlement><li>Utrecht</li></settlement></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Van Der Maas, N" sort="Van Der Maas, N" uniqKey="Van Der Maas N" first="N" last="Van Der Maas">N. Van Der Maas</name></noRegion><name sortKey="De Melker, H" sort="De Melker, H" uniqKey="De Melker H" first="H" last="De Melker">H. De Melker</name><name sortKey="Dijs Elsinga, J" sort="Dijs Elsinga, J" uniqKey="Dijs Elsinga J" first="J" last="Dijs-Elsinga">J. Dijs-Elsinga</name><name sortKey="Kemmeren, J" sort="Kemmeren, J" uniqKey="Kemmeren J" first="J" last="Kemmeren">J. Kemmeren</name><name sortKey="Knol, M" sort="Knol, M" uniqKey="Knol M" first="M" last="Knol">M. Knol</name><name sortKey="Van Lier, A" sort="Van Lier, A" uniqKey="Van Lier A" first="A" last="Van Lier">A. Van Lier</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000067 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000067 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippePaysBasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25754741
|texte= Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant's health: cross-sectional linkage study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25754741" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippePaysBasV1
| This area was generated with Dilib version V0.6.35. |  |